164 related articles for article (PubMed ID: 15114294)
1. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity.
Sepúlveda-Flores RN; Vera-Cabrera L; Flores-Gutiérrez JP; Maldonado-Garza H; Salinas-Garza R; Zorrilla-Blanco P; Bosques-Padilla FJ
Ann Hepatol; 2002; 1(1):36-9. PubMed ID: 15114294
[TBL] [Abstract][Full Text] [Related]
2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
4. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
5. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease.
Ma H; Gomez V; Lu L; Yang X; Wu X; Xiao SY
J Gastroenterol Hepatol; 2009 Feb; 24(2):233-7. PubMed ID: 18713296
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis.
Bechmann LP; Gieseler RK; Sowa JP; Kahraman A; Erhard J; Wedemeyer I; Emons B; Jochum C; Feldkamp T; Gerken G; Canbay A
Liver Int; 2010 Jul; 30(6):850-9. PubMed ID: 20408954
[TBL] [Abstract][Full Text] [Related]
8. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
Bedossa P; Poitou C; Veyrie N; Bouillot JL; Basdevant A; Paradis V; Tordjman J; Clement K
Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
11. Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery.
Chisholm J; Seki Y; Toouli J; Stahl J; Collins J; Kow L
Surg Obes Relat Dis; 2012; 8(4):416-22. PubMed ID: 21865094
[TBL] [Abstract][Full Text] [Related]
12. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
Keshishian A; Zahriya K; Willes EB
Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
[TBL] [Abstract][Full Text] [Related]
13. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
Abrams GA; Kunde SS; Lazenby AJ; Clements RH
Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
16. [Non alcoholic steatohepatitis].
Manero E; Findor JA; Avagnina A; de Elizalde S; Elsner B
Medicina (B Aires); 1994; 54(6):625-9. PubMed ID: 7658998
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of Ob-Rb and its relationship with the overexpression of TGF-beta1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis.
Cayón A; Crespo J; Mayorga M; Guerra A; Pons-Romero F
Liver Int; 2006 Nov; 26(9):1065-71. PubMed ID: 17032406
[TBL] [Abstract][Full Text] [Related]
18. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
19. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity.
Stratopoulos C; Papakonstantinou A; Terzis I; Spiliadi C; Dimitriades G; Komesidou V; Kitsanta P; Argyrakos T; Hadjiyannakis E
Obes Surg; 2005 Sep; 15(8):1154-60. PubMed ID: 16197789
[TBL] [Abstract][Full Text] [Related]
20. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
Dixon JB; Bhathal PS; O'Brien PE
Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]